Skip to content
OpenCapital
Get started

Veracyte VCYT Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$139.1MBeat by $8.7M
EPS$0.52Beat by $0.18
Revenue estimate$130.4M
EPS estimate$0.34

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$144.6M
EPS estimate$0.44

Financials

Q1 2026

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$4.44B+126%
Enterprise value$4.21B+135%
P/E50.4×-24.0×
P/S8.2×+4.1×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Segments

By segment

See full
Reportable Segment$139.1M+21.5%

By product

See full
Testing revenue$135.1M+25.9%

Versus estimates

Revenue

Q1 2026$139.1MBeat by $8.7M
Q4 2025$140.6MBeat by $4.8MQ3 2025$131.9MMiss by $3.9MQ2 2025$130.2MBeat by $5.8MQ1 2025$114.5MBeat by $3.5MQ4 2024$118.6MBeat by $7.9M

Diluted EPS

Q1 2026$0.52Beat by $0.18
Q4 2025$0.53Beat by $0.12Q3 2025$0.51Beat by $0.19Q2 2025$0.44Beat by $0.13Q1 2025$0.31Beat by $0.11Q4 2024$0.36Beat by $0.26

Ask the moment Veracyte reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Veracyte report Q1 2026 earnings?
Veracyte (VCYT) reported Q1 2026 earnings on May 5, 2026 after market close.
What were Veracyte's Q1 2026 revenue and EPS?
Veracyte reported revenue of $139.1M and eps of $0.52 for Q1 2026.
Did Veracyte beat estimates in Q1 2026?
Revenue beat the consensus estimate of $130.4M by $8.7M. EPS beat the consensus estimate of $0.34 by $0.18.
How did Veracyte's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.5% from $114.5M a year earlier and eps grew 67.7% from $0.31.
Where can I find Veracyte's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001384101-26-000029) and the 10-Q periodic report (0001384101-26-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.